HIV drug resistance testing is an important tool for understanding how human immunodeficiency virus responds to antiretroviral medications. Genetic changes in HIV can reduce the effectiveness of certain medicines, potentially making viral suppression more difficult to achieve or maintain. Resistance testing helps healthcare professionals identify these changes and evaluate which treatments may remain effective. The results are considered alongside viral load measurements, treatment history, medication adherence, and other clinical information. Understanding the purpose of resistance testing can help individuals receiving HIV care.
HIV drug resistance testing examines whether genetic changes in the virus may affect the activity of specific antiretroviral medicines. These tests are particularly relevant when treatment is being considered for someone newly diagnosed with HIV or when viral load remains detectable or increases during treatment.
Two commonly used approaches are genotypic and phenotypic resistance testing. Genotypic testing identifies changes in the virus's genetic material associated with resistance. Phenotypic testing evaluates how effectively HIV grows in the presence of particular antiretroviral medicines under laboratory conditions.
The choice of test depends on the clinical situation, previous treatment exposure, and available laboratory methods.
Genotypic testing: Identifies mutations associated with resistance to specific antiretroviral drug classes.
Phenotypic testing: Measures the virus's susceptibility to selected medicines in laboratory settings.
Baseline testing: Helps identify existing resistance before or around the time treatment begins.
Resistance testing during treatment: May help explain why viral suppression has not been achieved or maintained.
Specialized testing: Additional approaches may be considered in certain complex cases, depending on previous treatments and suspected resistance patterns.
Test results must be interpreted carefully because not every detected mutation has the same clinical significance. Some resistance-associated changes can persist even when they are no longer easily detected in a blood sample.
Resistance testing helps healthcare professionals select or adjust antiretroviral therapy according to the virus's characteristics. The findings are evaluated together with the patient's treatment history, viral load results, previous resistance reports, and other relevant clinical factors.
A resistance report does not independently determine the complete treatment plan. Instead, it provides evidence that supports decisions intended to achieve and maintain viral suppression.
Selecting medications: Results can help identify antiretroviral medicines that are more likely to remain effective against the individual's HIV strain.
Reviewing treatment failure: Detectable or increasing viral load may prompt an assessment of adherence, medication interactions, and possible resistance.
Evaluating previous treatments: Earlier resistance results can provide important information when reviewing future treatment options.
Considering drug interactions: Healthcare professionals may assess whether other medicines or supplements affect antiretroviral drug levels.
Monitoring treatment response: Follow-up viral load testing helps determine whether the selected treatment is successfully suppressing HIV.
Resistance testing has limitations. Results may not identify every resistant viral variant, particularly when a person has already stopped taking certain medications. Some tests may also be less informative when viral load is too low for reliable analysis. In these situations, healthcare professionals may consider previous laboratory reports and treatment records.
Consistent adherence to prescribed antiretroviral therapy remains important because missed doses or interruptions can contribute to treatment difficulties and, in some circumstances, resistance development. Individuals should discuss treatment concerns with their healthcare team rather than changing or stopping medication independently.
Understanding HIV drug resistance testing helps explain how laboratory findings contribute to individualized treatment decisions. By combining resistance results with viral load measurements, medication history, and clinical assessments, healthcare professionals can make better-informed decisions about antiretroviral therapy. Continued monitoring and appropriate follow-up are important for maintaining viral suppression and supporting long-term HIV management. This article is intended for informational purposes only and does not provide medical treatment or healthcare services.